221 related articles for article (PubMed ID: 35171025)
1. Lipid and Nucleocapsid N-Protein Accumulation in COVID-19 Patient Lung and Infected Cells.
Grootemaat AE; van der Niet S; Scholl ER; Roos E; Schurink B; Bugiani M; Miller SE; Larsen P; Pankras J; Reits EA; van der Wel NN
Microbiol Spectr; 2022 Feb; 10(1):e0127121. PubMed ID: 35171025
[TBL] [Abstract][Full Text] [Related]
2. Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis.
Nardacci R; Colavita F; Castilletti C; Lapa D; Matusali G; Meschi S; Del Nonno F; Colombo D; Capobianchi MR; Zumla A; Ippolito G; Piacentini M; Falasca L
Cell Death Dis; 2021 Mar; 12(3):263. PubMed ID: 33712574
[TBL] [Abstract][Full Text] [Related]
3. Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression.
El Jamal SM; Pujadas E; Ramos I; Bryce C; Grimes ZM; Amanat F; Tsankova NM; Mussa Z; Olson S; Salem F; Miorin L; Aydillo T; Schotsaert M; Albrecht RA; Liu WC; Marjanovic N; Francoeur N; Sebra R; Sealfon SC; García-Sastre A; Fowkes M; Cordon-Cardo C; Westra WH
Hum Pathol; 2021 Aug; 114():110-119. PubMed ID: 33961839
[TBL] [Abstract][Full Text] [Related]
4. Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues.
Massoth LR; Desai N; Szabolcs A; Harris CK; Neyaz A; Crotty R; Chebib I; Rivera MN; Sholl LM; Stone JR; Ting DT; Deshpande V
Am J Surg Pathol; 2021 Jan; 45(1):14-24. PubMed ID: 32826529
[TBL] [Abstract][Full Text] [Related]
5. Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells.
Barreto-Vieira DF; da Silva MAN; Garcia CC; Miranda MD; Matos ADR; Caetano BC; Resende PC; Motta FC; Siqueira MM; Girard-Dias W; Archanjo BS; Barth OM
Mem Inst Oswaldo Cruz; 2021; 116():e200443. PubMed ID: 33566951
[TBL] [Abstract][Full Text] [Related]
6. Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV.
Yasui F; Kai C; Kitabatake M; Inoue S; Yoneda M; Yokochi S; Kase R; Sekiguchi S; Morita K; Hishima T; Suzuki H; Karamatsu K; Yasutomi Y; Shida H; Kidokoro M; Mizuno K; Matsushima K; Kohara M
J Immunol; 2008 Nov; 181(9):6337-48. PubMed ID: 18941225
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of antibody response, virus neutralization efficiency & metabolites in SARS-CoV-2-infected adults & children.
Sudhakar R; Dontamala S; Bingi TC; Gorde S; Panda A; Rizvi Z; Reddy GS; Kaswan S; Bhattacharjee M; Kumar D; Nivya MA; Mesipogu RR; Varadarajan KS; Patel AB; Gupta D; Harshan KH; Tallapaka KB; Sijwali PS
Indian J Med Res; 2022; 156(4&5):659-668. PubMed ID: 36926783
[TBL] [Abstract][Full Text] [Related]
9. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
Ogando NS; Dalebout TJ; Zevenhoven-Dobbe JC; Limpens RWAL; van der Meer Y; Caly L; Druce J; de Vries JJC; Kikkert M; Bárcena M; Sidorov I; Snijder EJ
J Gen Virol; 2020 Sep; 101(9):925-940. PubMed ID: 32568027
[TBL] [Abstract][Full Text] [Related]
10. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus.
Yu CJ; Chen YC; Hsiao CH; Kuo TC; Chang SC; Lu CY; Wei WC; Lee CH; Huang LM; Chang MF; Ho HN; Lee FJ
FEBS Lett; 2004 May; 565(1-3):111-6. PubMed ID: 15135062
[TBL] [Abstract][Full Text] [Related]
12. Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells.
Wang X; Zhao Y; Yan F; Wang T; Sun W; Feng N; Wang W; Wang H; He H; Yang S; Xia X; Gao Y
J Virol; 2021 Aug; 95(18):e0060021. PubMed ID: 34106002
[TBL] [Abstract][Full Text] [Related]
13. Cell type-specific cleavage of nucleocapsid protein by effector caspases during SARS coronavirus infection.
Diemer C; Schneider M; Seebach J; Quaas J; Frösner G; Schätzl HM; Gilch S
J Mol Biol; 2008 Feb; 376(1):23-34. PubMed ID: 18155731
[TBL] [Abstract][Full Text] [Related]
14. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
Takamatsu Y; Imai M; Maeda K; Nakajima N; Higashi-Kuwata N; Iwatsuki-Horimoto K; Ito M; Kiso M; Maemura T; Takeda Y; Omata K; Suzuki T; Kawaoka Y; Mitsuya H
J Virol; 2022 Feb; 96(4):e0155121. PubMed ID: 34818068
[TBL] [Abstract][Full Text] [Related]
15. Hunting coronavirus by transmission electron microscopy - a guide to SARS-CoV-2-associated ultrastructural pathology in COVID-19 tissues.
Hopfer H; Herzig MC; Gosert R; Menter T; Hench J; Tzankov A; Hirsch HH; Miller SE
Histopathology; 2021 Feb; 78(3):358-370. PubMed ID: 32981112
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins.
Prentice E; McAuliffe J; Lu X; Subbarao K; Denison MR
J Virol; 2004 Sep; 78(18):9977-86. PubMed ID: 15331731
[TBL] [Abstract][Full Text] [Related]
17. Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage.
Deinhardt-Emmer S; Wittschieber D; Sanft J; Kleemann S; Elschner S; Haupt KF; Vau V; Häring C; Rödel J; Henke A; Ehrhardt C; Bauer M; Philipp M; Gaßler N; Nietzsche S; Löffler B; Mall G
Elife; 2021 Mar; 10():. PubMed ID: 33781385
[TBL] [Abstract][Full Text] [Related]
18. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.
Meng F; Siu GK; Mok BW; Sun J; Fung KSC; Lam JY; Wong NK; Gedefaw L; Luo S; Lee TMH; Yip SP; Huang CL
Cells; 2021 Jul; 10(7):. PubMed ID: 34359932
[TBL] [Abstract][Full Text] [Related]
19. Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses.
Ye C; Chiem K; Park JG; Silvas JA; Morales Vasquez D; Sourimant J; Lin MJ; Greninger AL; Plemper RK; Torrelles JB; Kobie JJ; Walter MR; de la Torre JC; Martinez-Sobrido L
Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34561300
[TBL] [Abstract][Full Text] [Related]
20. A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications.
Min YQ; Huang M; Feng K; Jia Y; Sun X; Ning YJ
Mol Cell Proteomics; 2023 Jul; 22(7):100579. PubMed ID: 37211047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
